Functional roles for T cell CD40 in infection and autoimmune disease: The role of CD40 in lymphocyte homeostasis

Seminars in Immunology

Volumn 21, Issue 5, 2009, Pages 283-288

  Munroe, Melissa E ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

CD40; CD4+ T cells; CD8+ T cells; Costimulation; Signaling

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD69 ANTIGEN; CD8 ANTIGEN; CD86 ANTIGEN; FAS ANTIGEN; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NFAT; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ADAPTIVE IMMUNITY; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BACTERIAL IMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGICAL TOLERANCE; INFECTION; INFLAMMATION; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRUS IMMUNITY;

ANIMALS; ANTIGENS, CD40; AUTOIMMUNE DISEASES; HOMEOSTASIS; HUMANS; INFECTION; LYMPHOCYTE ACTIVATION; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 70349085260     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smim.2009.05.008     Document Type: Review

References (58)

1. Bishop G.A., and Hostager B.S. The CD40-CD154 interaction in B cell-T cell liaisons. Cytokine Growth Factor Rev 14 (2003) 297-309
2. O'Sullivan B., and Thomas R. CD40 and dendritic cell function. Crit Rev Immunol 23 (2003) 83-107
3. Stout R.D., and Suttles J. The many roles of CD40 in cell-mediated inflammatory responses. Immunol Today 17 (1996) 487-492
4. Roy M., Aruffo A., Ledbetter J., Linsley P., Kehry M., and Noelle R. Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses. Eur J Immunol 25 (1995) 596-603
5. Mackey M.F., Barth Jr. R.J., and Noelle R.J. The role of CD40/CD154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells. J Leuk Biol 63 (1998) 418-428
6. + CTL response. J Exp Med 183 (1996) 2129-2142
7. Schoenberger S.P., Toes R.E., van der Voort E.I., Offringa R., and Melief C.J. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393 (1998) 480-483
8. + T cell help. J Immunol 178 (2007) 2844-2852
9. Smith C.M., Wilson N.S., Waithman J., Villadangos J.A., Carbone F.R., Heath W.R., et al. Cognate CD4(+) T cell licensing of dendritic cells in CD8(+) T cell immunity. Nat Immunol 5 (2004) 1143-1148
10. Johnson S., Zhan Y., Sutherland R.M., Mount A.M., Bedoui S., Brady J.L., et al. Selected Toll-like receptor ligands and viruses promote helper-independent cytotoxic T cell priming by upregulating CD40L on dendritic cells. Immunity 30 (2009) 218-227
11. Armitage R.J., Tough T.W., Macduff B.M., Fanslow W.C., Spriggs M.K., Ramsdell F., et al. CD40 ligand is a T cell growth factor. Eur J Immunol 23 (1993) 2326-2331
12. Fanslow W.C., Clifford K.N., Seaman M., Alderson M.R., Spriggs M.K., Armitage R.J., et al. Recombinant CD40 ligand exerts potent biologic effects on T cells. J Immunol 152 (1994) 4262-4269
13. + T cell memory. Science 297 (2002) 2060-2063
14. Lee B.O., Hartson L., and Randall T.D. CD40-deficient, influenza-specific CD8 memory T cells develop and function normally in a CD40-sufficient environment. J Exp Med 198 (2003) 1759-1764
15. Sun J.C., and Bevan M.J. Cutting edge: long-lived CD8 memory and protective immunity in the absence of CD40 expression on CD8 T cells. J Immunol 172 (2004) 3385-3389
16. Wagner Jr. D.H., Newell E., Sanderson R.J., Freed J.H., and Newell M.K. Increased expression of CD40 on thymocytes and peripheral T cells in autoimmunity: a mechanism for acquiring changes in the peripheral T cell receptor repertoire. Int J Mol Med 4 (1999) 231-242
17. + T cells (TCD40) in human type 1 diabetes. Clin Immunol 124 (2007) 138-148
18. Baker R.L., Wagner Jr. D.H., and Haskins K. CD40 on NOD CD4 T cells contributes to their activation and pathogenicity. J Autoimmun 31 (2008) 385-392
19. + auto-aggressive T cell expansion during insulin-dependent diabetes mellitus. Eur J Immunol 34 (2004) 1488-1497
20. Wagner Jr. D.H., Vaitaitis G., Sanderson R., Poulin M., Dobbs C., and Haskins K. Expression of CD40 identifies a unique pathogenic T cell population in type 1 diabetes. Proc Natl Acad Sci USA 99 (2002) 3782-3787
21. Munroe M.E., and Bishop G.A. A costimulatory function for T cell CD40. J Immunol 178 (2007) 671-682
22. Vaitaitis G.M., and Wagner Jr. D.H. High distribution of CD40 and TRAF2 in Th40 T cell rafts leads to preferential survival of this auto-aggressive population in autoimmunity. PLoS ONE 3 (2008) e2076
23. Vaitaitis G.M., Poulin M., Sanderson R.J., Haskins K., and Wagner Jr. D.H. Cutting edge: CD40-induced expression of recombination activating gene (RAG) 1 and RAG2: a mechanism for the generation of autoaggressive T cells in the periphery. J Immunol 170 (2003) 3455-3459
24. Cooper C.J., Turk G.L., Sun M., Farr A.G., and Fink P.J. Cutting edge: TCR revision occurs in germinal centers. J Immunol 173 (2004) 6532-6536
25. Cooper C.J., Orr M.T., McMahan C.J., and Fink P.J. T cell receptor revision does not solely target recent thymic emigrants. J Immunol 171 (2003) 226-233
26. Pollard K.M., Arnush M., Hultman P., and Kono D.H. Costimulation requirements of induced murine systemic autoimmune disease. J Immunol 173 (2004) 5880-5887
27. Bertram E.M., Dawicki W., and Watts T.H. Role of T cell costimulation in anti-viral immunity. Sem Immunol 16 (2004) 185-196
28. Haxhinasto S.A., Hostager B.S., and Bishop G.A. Cutting edge: molecular mechanisms of synergy between CD40 and the B Cell antigen receptor: role for TNF receptor-associated factor 2 in receptor interaction. J Immunol 169 (2002) 1145-1149
29. Behrens G., Li M., Smith C.M., Belz G.T., Mintern J., Carbone F.R., et al. Helper T cells, dendritic cells and CTL Immunity. Immunol Cell Biol 82 (2004) 84-90
30. Prlic M., Williams M.A., and Bevan M.J. Requirements for CD8 T-cell priming, memory generation and maintenance. Curr Opin Immunol 19 (2007) 315-319
31. Durand V., Wong S.Y., Tough D.F., and Le Bon A. Shaping of adaptive immune responses to soluble proteins by TLR agonists: a role for IFN-alpha/beta. Immunol Cell Biol 82 (2004) 596-602
32. Shaulov A., and Murali-Krishna K. CD8 T cell expansion and memory differentiation are facilitated by simultaneous and sustained exposure to antigenic and inflammatory milieu. J Immunol 180 (2008) 1131-1138
33. Bennett S.R., Carbone F.R., Karamalis F., Flavell R.A., Miller J.F., and Heath W.R. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393 (1998) 478-480
34. Toubi E., and Shoenfeld Y. The role of CD40-CD154 interactions in autoimmunity and the benefit of disrupting this pathway. Autoimmunity 37 (2004) 457-464
35. Datta S.K. Production of pathogenic antibodies: cognate interactions between autoimmune T and B cells. Lupus 7 (1998) 591-596
36. +) T cells promotes diabetes. J Leuk Biol 84 (2008) 431-439
37. Bishop G.A., Warren W.D., and Berton M.T. Signaling via major histocompatibility complex class II molecules and antigen receptors enhances the B cell response to gp39/CD40 ligand. Eur J Immunol 25 (1995) 1230-1238
38. Lederman S., Yellin M.J., Cleary A.M., Pernis A., Inghirami G., Cohn L.E., et al. T-BAM/CD40-L on helper T lymphocytes augments lymphokine-induced B cell Ig isotype switch recombination and rescues B cells from programmed cell death. J Immunol 152 (1994) 2163-2171
39. Benson R.J., Hostager B.S., and Bishop G.A. Rapid CD40-mediated rescue from CD95-induced apoptosis requires TNFR-associated factor-6 and PI3K. Eur J Immunol 36 (2006) 2535-2543
40. Eeva J., Ropponen A., Nuutinen U., Eeva S.T., Matto M., Eray M., et al. The CD40-induced protection against CD95-mediated apoptosis is associated with a rapid upregulation of anti-apoptotic c-FLIP. Mol Immunol 44 (2006) 1230-1237
41. Isakov N., and Altman A. Protein kinase C(theta) in T cell activation. Ann Rev Immunol 20 (2002) 761-794
42. Cianferoni A., Massaad M., Feske S., de la Fuente M.A., Gallego L., Ramesh N., et al. Defective nuclear translocation of nuclear factor of activated T cells and extracellular signal-regulated kinase underlies deficient IL-2 gene expression in Wiskott-Aldrich syndrome. J Allergy Clin Immunol 116 (2005) 1364-1371
43. Flescher E., Ledbetter J.A., Ogawa N., Vela-Roch N., Fossum D., Dang H., et al. Induction of transcription factors in human T lymphocytes by aspirin-like drugs. Cell Immunol 160 (1995) 232-239
44. Kaminuma O., Elly C., Tanaka Y., Mori A., Liu Y.C., Altman A., et al. Vav-induced activation of the human IFN-gamma gene promoter is mediated by upregulation of AP-1 activity. FEBS Lett 514 (2002) 153-158
45. Sica A., Dorman L., Viggiano V., Cippitelli M., Ghosh P., Rice N., et al. Interaction of NF-kappaB and NFAT with the interferon-gamma promoter. J Biol Chem 272 (1997) 30412-30420
46. Li-Weber M., Treiber M.K., Giaisi M., Palfi K., Stephan N., Parg S., et al. Ultraviolet irradiation suppresses T cell activation via blocking TCR-mediated ERK and NF-kappa B signaling pathways. J Immunol 175 (2005) 2132-2143
47. Gerlag D.M., Ransone L., Tak P.P., Han Z., Palanki M., Barbosa M.S., et al. The effect of a T cell-specific NF-kappa B inhibitor on in vitro cytokine production and collagen-induced arthritis. J Immunol 165 (2000) 1652-1658
48. Munroe M.E., Arbiser J., and Bishop G.A. Honokiol, a natural plant product, inhibits inflammatory signals and alleviates inflammatory arthritis. J Immunol 179 (2007) 753-763
49. Baccam M., Woo S.Y., Vinson C., and Bishop G.A. CD40-mediated transcriptional regulation of the IL-6 gene in B lymphocytes: involvement of NF-kappa B, AP-1, and C/EBP. J Immunol 170 (2003) 3099-3108
50. Hsing Y., and Bishop G.A. Requirement for nuclear factor-kappaB activation by a distinct subset of CD40-mediated effector functions in B lymphocytes. J Immunol 162 (1999) 2804-2811
51. Hillion S., Rochas C., Youinou P., and Jamin C. Expression and reexpression of recombination activating genes: relevance to the development of autoimmune states. Ann NY Acad Sci 1050 (2005) 10-18
52. Anderson M.K. At the crossroads: diverse roles of early thymocyte transcriptional regulators. Immunol Rev 209 (2006) 191-211
53. + T cells. J Exp Med 176 (1992) 1733-1738
54. Fink P.J., and McMahan C.J. Lymphocytes rearrange, edit and revise their antigen receptors to be useful yet safe. Immunol Today 21 (2000) 561-566
55. Petrie H.T., Livak F., Schatz D.G., Strasser A., Crispe I.N., and Shortman K. Multiple rearrangements in T cell receptor alpha chain genes maximize the production of useful thymocytes. J Exp Med 178 (1993) 615-622
56. Zehn D., Bevan M.J., and Fink P.J. Cutting edge: TCR revision affects predominantly Foxp3 cells and skews them toward the Th17 lineage. J Immunol 179 (2007) 5653-5657
57. + T lymphocytes. Proc Natl Acad Sci USA 99 (2002) 15566-15571
58. Schultze J.L., Grabbe S., and von Bergwelt-Baildon M.S. DCs and CD40-activated B cells: current and future avenues to cellular cancer immunotherapy. Trends Immunol 25 (2004) 659-664